Adherence to dipeptidyl peptidase‐4 inhibitor therapy among type 2 diabetes patients with employer‐sponsored health insurance in Japan

AIMS/INTRODUCTION: Dipeptidyl peptidase‐4 inhibitors (DPP‐4i) are a common first‐line treatment for type 2 diabetes in Japan. However, little is known about patients’ medication adherence, persistence and discontinuation in this setting. MATERIALS AND METHODS: This was a retrospective cohort study o...

Descripción completa

Detalles Bibliográficos
Autores principales: Kurtyka, Karen, Nishikino, Rie, Ito, Chie, Brodovicz, Kim, Chen, Yong, Tunceli, Kaan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5009136/
https://www.ncbi.nlm.nih.gov/pubmed/27182033
http://dx.doi.org/10.1111/jdi.12474

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5009136/
https://www.ncbi.nlm.nih.gov/pubmed/27182033
http://dx.doi.org/10.1111/jdi.12474

Ejemplares similares